Clinical Trials Logo

Clinical Trial Summary

Why does acute post whiplash injury pain transform into chronic pain? Multi-modal assessment of risk factors and predictors of pain chronification


Clinical Trial Description

Background The proposed study aims to explore why acute pain turns, in some patients, into chronic pain, and to develop tools for prediction of this transition. Based on the clinical and psychological assessment along with psychophysical and neurophysiological assessment of pain perception, with the analysis of connectivity between several brain centers relevant for pain processing, together with pain genetics, we expect to develop a tool, that will predict, for the individual patient with acute pain inflicted by a whiplash injury, what are the chances for him/her to go into chronic pain situation. Further, by knowing the dysfunctions of pain processing that a patient has, it will be possible to offer the treatment of highest chances to succeed. Our specific aims are to evaluate, in the setup of acute whiplash injury, the risk of transition to chronic pain based on each of the following testing domains: (i) Psychophysical and neurophysiological data describing facilitatory and inhibitory modulation capacity of the patient. (ii) Psychological data describing patient's behavior such as catastrophizing, fear of pain, post-traumatic stress and depressed mood. (iii) Structural and functional neuro-imaging data describing brain anatomy and function, where we assess resting state MRI activity, grey matter properties using T1 weighted imaging, and white matter properties using diffusion tensor imaging. (iv) Genetic data describing the genetic epidemiology of every patient for the examination of genetic variants associated with transition to chronic pain, and (v) individual case data related to age, gender, education, socioeconomic parameters and personal medical history, as well as features of the specific injury. Overall, we aim to construct a composite scoring system, based on the most relevant of the above mentioned parameters, yielding the highest relative predictive value in identifying acute pain patients who have higher risk for chronification. Subjects One hundred and twenty healthy subjects (range 20-79; 20 subjects per age decade, 10 M and 10 F) will participate in the first phase of the study aimed to collect normative data from healthy population. Seven hundred and fifty acute whiplash-injury based mild traumatic brain injuries (TBI) will participate in this study. Study design Phase I - Normative data collection for the inhibitory and excitatory pain modulation responses, a study on healthy subjects Phase II - Multi-modal assessment of acute mild TBI whiplash patients and follow-up 1. Initial experimental assessment, will consist, in most cases, of two sessions, one during the ER visit, and the next within 72 hrs of injury, pending on team and device availability, such that all tests will be completed, as follows: 1. Physical examination with a full neurological exam, and assessment of neck movement. 2. Psychophysical pain measurements: i. Pain thresholds. ii. Suprathreshold pain magnitude estimation; iii. Mechanical temporal summation (TS) and electrical TS iv. Conditioned pain modulation (CPM) - as described for the phase I protocol. It is noted that similar protocols of pain measurement are commonly performed in many labs worldwide in many acute and chronic pain setups, and are considered safe, with no damaging effect on the disease state. c. Psychological examination via filling questionnaires for evaluation the following variables: i. Pain Catastrophizing ii. Depression iii. Post-traumatic Diagnostic Scale (PDS) iv. Fear of pain v. The perceived stress of the subjects is assessed by the validated Hebrew version Cohen's Perceived Stress Scale (PSS). vi. Five factor model (FFM) d.Blood collection for genetics. Whole blood sample (10cc) will be collected from each subject and placed in Ethylenediaminetetraacetic acid (EDTA)-coated tubes. Genomic DNA will be isolated using DNA Extraction Kit . Quality and quantity of the DNA sample will be measured using a NanoDrop Machine. e. Magnetic resonance imaging (MRI)/Functional MRI (fMRI) examination in a 3T scanner. f. Neurophysiological assessment of pain modulation with 64-channel EEG recording (Brain Products GmbH, Munich, Germany) of CPM and TS. i.Neurophysiological assessment of CPM ii.Neurophysiological assessment of TS will be based on electrical evoked potentials obtained with a constant current stimulator 2. Follow up Patients will self-report their pain levels and use of analgesics once in two weeks. At 6 and 12 month visits patients will be invited to repeat the psychophysical and neurophysiological pain assessments and psychological questionnaires. Selected patients will undergo a second MRI assessment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02560675
Study type Observational
Source Rambam Health Care Campus
Contact
Status Completed
Phase
Start date January 2016
Completion date September 15, 2021

See also
  Status Clinical Trial Phase
Completed NCT04822311 - Evaluating the Impact of Focused Muscle Contraction Therapy in Retire APF Players N/A
Completed NCT04105998 - Effects of Intramuscular (IM) Oxytocin on Pupil Diameter and Heart Rate Variability (HRV) Phase 4
Active, not recruiting NCT01967342 - Literacy-Adapted Psychosocial Treatments for Chronic Pain --- "Learning About Mastering/My Pain" N/A
Recruiting NCT03944447 - Outcomes Mandate National Integration With Cannabis as Medicine Phase 2
Completed NCT03119896 - Supporting Self-management of Chronic Pain N/A